Fc gamma RIIa (CD32) polymorphism and onchocercal skin disease: implications for the development of severe reactive onchodermatitis (ROD)

Am J Trop Med Hyg. 2007 Dec;77(6):1074-8.

Abstract

The pathologic manifestations of Onchocerca volvulus infection depend on the interplay between the host and the parasite. A genetic single nucleotide polymorphism in the Fc gamma RIIa gene, resulting in arginine (R) or histidine (H) at position 131, affects the binding to the different IgG subclasses and may influence the clinical variations seen in onchocerciasis. This study investigated the relationship between this polymorphism and disease outcome. Fc gamma RIIa genotyping was performed on clinically characterized onchocerciasis patients (N = 100) and healthy controls (N = 74). Fc gamma RIIa genotype R/R131 frequencies were significantly higher among patients with severe dermatopathology (P < 0.001). Increased risk of developing this form was mostly associated with one tribe (Masalit) (OR = 3.2, 95% CI 1-9.9, P = 0.042). The H131 allele was found to be significantly associated with a reduced risk of having the severe form of the disease (adjusted OR = 0.26, 95% CI = 0.13-0.46, P < 0.001). Our findings suggest that the polymorphism influences the clinical outcome of onchocerciasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Antigens, CD / genetics*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • DNA Primers / chemistry
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Infant
  • Male
  • Onchocerca volvulus / pathogenicity*
  • Onchocerciasis / genetics*
  • Onchocerciasis / pathology
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Receptors, IgG / genetics*
  • Risk Factors
  • Severity of Illness Index
  • Sudan / epidemiology

Substances

  • Antigens, CD
  • DNA Primers
  • Fc gamma receptor IIA
  • Receptors, IgG